{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:06:16Z","timestamp":1761717976008},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1995,8,1]],"date-time":"1995-08-01T00:00:00Z","timestamp":807235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1007\/bf02212711","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T02:39:47Z","timestamp":1128566387000},"page":"1842-1844","source":"Crossref","is-referenced-by-count":27,"title":["Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B"],"prefix":"10.1007","volume":"40","author":[{"given":"Janusz","family":"Cianciara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Laskus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02212711_CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","volume":"115","author":"LE Ronnnblom","year":"1991","unstructured":"Ronnnblom LE, Alm GV, \u00d6berg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 115:178\u2013183, 1991","journal-title":"Ann Intern Med"},{"key":"BF02212711_CR2","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5","volume":"10","author":"KC Conlon","year":"1990","unstructured":"Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW: Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 10:2237\u20132242, 1990","journal-title":"Cancer"},{"key":"BF02212711_CR3","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","volume":"102","author":"M Lisker-Melman","year":"1992","unstructured":"Lisker-Melman M, Di Bisciegle AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 102:2155\u20132160, 1992","journal-title":"Gastroenterology"},{"key":"BF02212711_CR4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(89)91595-X","volume":"2","author":"S Vento","year":"1989","unstructured":"Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T, Bassetti D: Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 2:926, 1989","journal-title":"Lancet"},{"key":"BF02212711_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-8278(05)80258-2","volume":"18","author":"L Muratori","year":"1993","unstructured":"Muratori L, Zuli D, Giostra F, Ballardini G, Lenzi M, Cassani F, Bianchi FB: LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment. J Hepatol 18:259\u2013260, 1993","journal-title":"J Hepatol"},{"key":"BF02212711_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0168-8278(91)90953-9","volume":"12","author":"M Ruiz-Moreno","year":"1991","unstructured":"Ruiz-Moreno M, Rua MJ, Carreno V, Quiroga JA, Manns M, Meyer zum B\u00fcschenfelde K-H: Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children. J Hepatol 12:265\u2013266, 1991","journal-title":"J Hepatol"},{"key":"BF02212711_CR7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0016-5085(91)90547-X","volume":"101","author":"MO Silva","year":"1991","unstructured":"Silva MO, Reddy KR, Jeffers LJ, Hill M, Schiff ER: Interferon-induced chronic active hepatitis? Gastroenterology 101:840\u2013844, 1991","journal-title":"Gastroenterology"},{"key":"BF02212711_CR8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0016-5085(93)90964-E","volume":"105","author":"T Laskus","year":"1993","unstructured":"Laskus T, Mosley JW, Nowicki M, Persing DH: Prevalence and nucleotide sequence analysis of pre-core mutations among patients with fulminant hepatitis in the USA. Gastroenterology 105:1173\u20131178, 1993","journal-title":"Gastroenterology"},{"key":"BF02212711_CR9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.266.6.849","volume":"266","author":"J Hoofnagle","year":"1991","unstructured":"Hoofnagle J: Thrombocytopenia during interferon alpha therapy. JAMA 266:849, 1991","journal-title":"JAMA"},{"key":"BF02212711_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0168-8227(94)90124-4","volume":"23","author":"M Waguri","year":"1994","unstructured":"Waguri M, Hanafusa T, Itoh N, Imagawa A, Miyagawa J, Kawata S, Kono N, Kuwajima M, Masuzawa Y: Occurrence of IDDM during interferon therapy for chronic viral hepatitis. Diab Res Clin Prac 23:33\u201336, 1994","journal-title":"Diab Res Clin Prac"},{"key":"BF02212711_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840100106","volume":"10","author":"W-J Mayet","year":"1989","unstructured":"Mayet W-J, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum B\u00fcschenfelde K-H: Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10:24\u201328, 1989","journal-title":"Hepatology"},{"key":"BF02212711_CR12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(94)80002-2","volume":"20","author":"P Weber","year":"1994","unstructured":"Weber P, Wiedmann K-H, Klein E, Blum HE, Berg PA: Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon. J Hepatol 20:321\u2013328, 1994","journal-title":"J Hepatol"},{"key":"BF02212711_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-2008-1040516","volume":"4","author":"M Peters","year":"1989","unstructured":"Peters M: Mechanism of action of interferons. Semin Liver Dis 4:235\u2013239, 1989","journal-title":"Semin Liver Dis"},{"key":"BF02212711_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00201966","volume":"7","author":"H Kirchner","year":"1984","unstructured":"Kirchner H: Interferons, a group of multiple lymphokines. Springer Semin Immunopathol 7:347\u2013374, 1984","journal-title":"Springer Semin Immunopathol"},{"key":"BF02212711_CR15","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.4049\/jimmunol.133.5.2412","volume":"133","author":"J Knop","year":"1984","unstructured":"Knop J, Stremmer R, Taborsky U, Freitag W, de Maeyer-Guignard J, Macher E: Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon. J Immunol 133:2412\u20132416, 1984","journal-title":"J Immunol"},{"key":"BF02212711_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.1840080302","volume":"8","author":"A Franco","year":"1988","unstructured":"Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F: Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 8:449\u2013454, 1988","journal-title":"Hepatology"},{"key":"BF02212711_CR17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(83)90629-3","volume":"2","author":"GF Bottazzo","year":"1983","unstructured":"Bottazzo GF, Pujol-Borrell R, Hanafusa T: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115\u20131118, 1983","journal-title":"Lancet"},{"key":"BF02212711_CR18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0140-6736(85)90203-X","volume":"2","author":"P Burman","year":"1985","unstructured":"Burman P, Karlsson FA, \u00d6berg K, Alm G: Autoimmune thyroid disease in interferon-treated patients. Lancet 2:100\u2013101, 1985","journal-title":"Lancet"},{"key":"BF02212711_CR19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00000441-198806000-00007","volume":"295","author":"A Schattner","year":"1988","unstructured":"Schattner A: Review: Interferons and autoimmunity. Am J Med Sci 295:532\u2013544, 1988","journal-title":"Am J Med Sci"},{"key":"BF02212711_CR20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(74)90287-6","volume":"2","author":"ALWF Eddleston","year":"1974","unstructured":"Eddleston ALWF, Williams R: Inadequate antibody response to Hbs antigen or suppressor T-cell defect in development of active chronic hepatitis. Lancet 2:1543\u20131548, 1974","journal-title":"Lancet"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02212711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02212711\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02212711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T23:55:47Z","timestamp":1683244547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02212711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["BF02212711"],"URL":"https:\/\/doi.org\/10.1007\/bf02212711","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}